author-photo

R. Griffiths

Clatterbridge Cancer Centre NHS Foundation Trust

7

Papers

184

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (54)
Tivozanib as first-line treatment of metastatic renal cell carcinoma: A real-world outcome review in North-West of England, United Kingdom.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

2019 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (18)
Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (14)
1303PDNivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (24)
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

2016 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (69)
1477PA NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)